Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses 2.3 B2.63 B2.28 B 9.52 B Research & development ——— — Operating income 169 M401 M249 M 429 M Non-Operating Income, Total 20 M16 M2 M 58 M Interest expense, net of interest capitalized 86 M85 M82 M 341 M Non-Operating Income, excl. Interest Expenses -66 M-69 M-80 M -283 M Unusual income/expense ——— — Pretax income 109 M333 M179 M 170 M Equity in earnings ——— — Taxes 62 M171 M90 M 418 M Non-controlling/minority interest ——— — After tax other income/expense 2 M10 M-15 M -2 M Net income before discontinued operations 47 M162 M89 M -248 M Discontinued operations ——— — Net income 47 M162 M89 M -248 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 47 M162 M89 M -248 M Basic earnings per share (Basic EPS) 0.130.450.25 -0.69 Diluted earnings per share (Diluted EPS) 0.130.440.24 -0.71 Average basic shares outstanding 361.2 M362.1 M362.7 M — Diluted shares outstanding 363.3 M364.8 M365.4 M — EBITDA 369 M598 M450 M 1.24 B EBIT 169 M401 M249 M 429 M Cost of revenue 927 M994 M876 M 3.75 B Other cost of goods sold ——— — Depreciation & amortization (cash flow) 200 M197 M201 M 808 M